» Articles » PMID: 32801994

Significance of Omega-3 Fatty Acids in the Prophylaxis and Treatment After Spinal Cord Injury in Rodent Models

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2020 Aug 18
PMID 32801994
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Polyunsaturated fatty acids (-3 acids, PUFAs) are essential components of cell membranes in all mammals. A multifactorial beneficial influence of -3 fatty acids on the health of humans and other mammals has been observed for many years. Therefore, -3 fatty acids and their function in the prophylaxis and treatment of various pathologies have been subjected to numerous studies. Regarding the documented therapeutic influence of -3 fatty acids on the nervous and immune systems, the aim of this paper is to present the current state of knowledge and the critical assessment of the role of -3 fatty acids in the prophylaxis and treatment of spinal cord injury (SCI) in rodent models. The prophylactic properties (pre-SCI) include the stabilization of neuron cell membranes, the reduction of the expression of inflammatory cytokines (IL-1, TNF-, IL-6, and KC/GRO/CINC), the improvement of local blood flow, reduced eicosanoid production, activation of protective intracellular transcription pathways (dependent on RXR, PPAR-, Akt, and CREB), and increased concentration of lipids, glycogen, and oligosaccharides by neurons. On the other hand, the therapeutic properties (post-SCI) include the increased production of endogenous antioxidants such as carnosine and homocarnosine, the maintenance of elevated GSH concentrations at the site of injury, reduced concentrations of oxidative stress marker (MDA), autophagy improvement (via increasing the expression of LC3-II), and p38 MAPK expression reduction in the superficial dorsal horns (limiting the sensation of neuropathic pain). Paradoxically, despite the well-documented protective activity of -3 acids in rodents with SCI, the research does not offer an answer to the principal question of the optimal dose and treatment duration. Therefore, it is worth emphasizing the role of multicenter rodent studies with the implementation of standards which initially may even be based on arbitrary criteria. Additionally, basing on available research data, the authors of this paper make a careful attempt at referring some of the conclusions to the human population.

Citing Articles

Efficacy of Omega-5 NanoPSO Treatment in the Hippocampus, Through Antioxidant Mechanisms, After an Ischemia/Reperfusion Injury, in Murine Model.

Aguilar-Garcia I, Alpirez J, Munoz-Valle J, Trujillo-Rangel W, Fernandez-Quezada D, Duenas-Jimenez S Antioxidants (Basel). 2024; 13(11).

PMID: 39594495 PMC: 11591363. DOI: 10.3390/antiox13111353.


ω-3 Polyunsaturated Fatty Acids Improve the Blood-Brain-Barrier Integrity in Contrast-Induced Blood-Brain-Barrier Injury in Uremic Mice.

Shin J, Park H, Choi H, Chang Y, Kim J, Ham Y Int J Mol Sci. 2023; 24(15).

PMID: 37569545 PMC: 10418677. DOI: 10.3390/ijms241512168.


Omega-3 Polyunsaturated Fatty Acids Protect Neurological Function After Traumatic Brain Injury by Suppressing Microglial Transformation to the Proinflammatory Phenotype and Activating Exosomal NGF/TrkA Signaling.

Lin L, Zheng S, Lai J, Ye D, Huang Q, Wu Z Mol Neurobiol. 2023; 60(10):5592-5606.

PMID: 37329381 DOI: 10.1007/s12035-023-03419-3.


Pathophysiology and Therapeutic Approaches for Spinal Cord Injury.

Lima R, Monteiro A, Salgado A, Monteiro S, Silva N Int J Mol Sci. 2022; 23(22).

PMID: 36430308 PMC: 9698625. DOI: 10.3390/ijms232213833.


Spinal Vascular Shunts: Single-Center Series and Review of the Literature of Their Classification.

Lizana J, Aliaga N, Marani W, Escribano A, Montemurro N Neurol Int. 2022; 14(3):581-599.

PMID: 35893282 PMC: 9326594. DOI: 10.3390/neurolint14030047.


References
1.
Figueroa J, Cordero K, Serrano-Illan M, Almeyda A, Baldeosingh K, Almaguel F . Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury. Neuroscience. 2013; 255:1-18. PMC: 3844071. DOI: 10.1016/j.neuroscience.2013.09.012. View

2.
Daak A, Elderdery A, Elbashir L, Mariniello K, Mills J, Scarlett G . Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-κB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease. Blood Cells Mol Dis. 2015; 55(1):48-55. DOI: 10.1016/j.bcmd.2015.03.014. View

3.
Sun X, Jones Z, Chen X, Zhou L, So K, Ren Y . Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation. 2016; 13(1):260. PMC: 5053065. DOI: 10.1186/s12974-016-0736-y. View

4.
Wu M, Harvey K, Ruzmetov N, Welch Z, Sech L, Jackson K . Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer. 2005; 117(3):340-8. DOI: 10.1002/ijc.21238. View

5.
Dumont R, Okonkwo D, Verma S, Hurlbert R, Boulos P, Ellegala D . Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol. 2001; 24(5):254-64. DOI: 10.1097/00002826-200109000-00002. View